Earnings Call · Q4 FY2024·2025-03-13

Q4 24EPS +97.16%·Rev n/aQ3 24EPS +0.89%·Rev n/aQ2 24EPS -6.67%·Rev n/aQ1 24EPS -31.36%·Rev n/a⚠ consensus missing

Cellectar Biosciences, Inc. CLRB

Anne Marie Fields — Investor Relations or Communications

Jim Caruso — President and CEO

Chad Kolean — Chief Financial Officer

Jarrod Longcor — Regulatory or Clinical Development Executive

−5.4%1d on move date−4.0% vs SPY3d+6.4%5d+21.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLRB calls or request research access.

More CLRB calls Browse calls Request research access